Frazier, Thomas W. http://orcid.org/0000-0002-6951-2667
Klingemier, Eric W.
Anderson, Christa J.
Gengoux, Grace W.
Youngstrom, Eric A.
Hardan, Antonio Y.
Funding for this research was provided by:
Cole Family Research Fund
Autism Speaks
Hartwell Foundation
Article History
Accepted: 27 January 2021
First Online: 8 February 2021
Compliance with Ethical Standards
:
: TWF has received funding or research support from, acted as a consultant to, received travel support from, and/or received a speaker’s honorarium from Quadrant Biosciences, Impel NeuroPharma, F. Hoffmann-La Roche AG Pharmaceuticals, the Cole Family Research Fund, Simons Foundation, Ingalls Foundation, Forest Laboratories, Ecoeos, IntegraGen, Kugona LLC, Shire Development, Bristol-Myers Squibb, Roche Pharma, National Institutes of Health, and the Brain and Behavior Research Foundation and has an investor stake in Autism EYES LLC. EWK has received support from Kugona LLC. EAY has consulted with Pearson, Lundbeck, Janssen, Joe Startup Technologies, and Western Psychological Services about psychological assessment, and received royalties from the American Psychological Association and Guilford Press. AYH has received research funding from Forest Pharmaceuticals and Bristol Myers Squibb and is a consultant to IntegraGen. GWG has consulted to Autism Speaks.
: This project was a secondary analysis of clinical data collected as part of routine practice. The local institutional review board reviewed and approved the creation of a database containing the clinical data for future research use including the analyses conducted for this study.
: As the data were collected as part of routine clinical practice, consent was not obtained but all patients at the site provide consent for clinical data collection as part of their clinic visit. The authors certify that the study was performed in accordance with the ethical standards as laid down in the 1964 Declaration of Helsinki and its later amendments.